GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)

China · Delayed Price · Currency is CNY

14.91

+0.14 (0.95%)

Jul 31, 2026, 3:00 PM CST

SHA:600771 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,440	1,369	1,221	1,284	1,131	854.22
Revenue Growth	11.21%	12.11%	-4.88%	13.56%	32.37%	-23.00%
Gross Profit	969.93	919.21	891.49	933.3	725.95	521.11
Operating Income	130.65	122.39	90.74	113.18	-226.68	-362.84
Net Income	66.2	63.04	74.45	90.08	-250.02	-316.24
Earnings Per Share	0.14	0.13	0.13	0.18	-0.51	-0.64
EPS Growth	-19.18%	0%	-27.78%	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Industry (Excluding Health Wine)	1,209
Pharmaceutical Business	79.84
Health Wine	61.88
Total	1,351

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	411.43	296.75	116.67	259.97	246.4	145.15
Total Debt	31.13	41.69	61.94	291.36	432.93	327.86
Net Cash (Debt)	380.3	255.06	54.74	-31.39	-186.54	-182.71
Net Cash Growth	128.97%	365.97%	-	-	-	-
Net Cash Per Share	0.78	0.53	0.10	-0.06	-0.38	-0.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	175.81	197.89	112.39	215.5	253.43	81.37
Capital Expenditures	-6.03	-6.24	-8.78	-2.51	-8.67	-18.19
Free Cash Flow	169.78	191.65	103.61	212.99	244.76	63.17
Free Cash Flow Growth	57.81%	84.97%	-51.35%	-12.98%	287.44%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	67.34%	67.13%	72.99%	72.69%	64.20%	61.00%
Operating Margin	9.07%	8.94%	7.43%	8.82%	-20.05%	-42.48%
Pretax Margin	7.77%	7.52%	6.62%	7.82%	-23.45%	-41.28%
Profit Margin	4.60%	4.60%	6.10%	7.02%	-22.11%	-37.02%
FCF Margin	11.79%	14.00%	8.48%	16.59%	21.65%	7.40%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	109.24	139.60	124.00	146.67	-	-
Forward PE	-	48.48	48.48	48.48	48.48	48.48
P/FCF Ratio	42.99	45.92	89.10	62.03	55.64	333.64
PS Ratio	5.07	6.43	7.56	10.29	12.04	24.67